38 min ago
New grant to fund multiple sclerosis trials, research
A new Commonwealth grant for researching multiple sclerosis is expected to advance existing research collaborations and enable new ones.
13 hrs ago
Express Scripts: Spending on specialty medications to grow 67 percent
Express Scripts expects spending on specialty medications in the U.S. to jump 67 percent by the end of 2015, according to a new company study released Tuesday.
Tue May 21, 2013
The Motley Fool
Another Multiple Sclerosis Winner for Biogen
In this video, health-care analyst David Williamson discusses Biogen's latest drug up for FDA approval.
The clinical potential of blood-proteomics in multiple sclerosis
The aetiology of multiple sclerosis remains unknown. This hampers molecular diagnosis and the discovery of bio-molecular markers.
Multiple Sclerosis Drug Plegridy (Peginterferon) Submitted for FDA Review
A biologics license application has been submitted to the FDA for approval of Plegridy , a pegylated subcutaneous injectable candidate for relapsing forms of multiple sclerosis .
Biogen Idec's Plegridy with the FDA now
Plegridya is Biogen Idec's newly developed subcutaneously administered multiple sclerosis drug therapy and it as just been announced today that it has been submitted to the FDA for the okay to put on the market.
Medical News Today
Researchers Able To Prevent And Cure Type 1 Diabetes In Animal Models
Main Category: Diabetes Also Included In: Immune System / Vaccines ; Multiple Sclerosis ; Arthritis / Rheumatology Article Date: 21 May 2013 - 1:00 PDT Melbourne researchers have identified an immune protein that has the potential to stop or reverse the development of type 1 diabetes in its early stages, before insulin-producing cells have been ... (more)
Multiple Sclerosis Drug Fails Phase III Trial
A pivotal phase III study of arbaclofen placarbil for the treatment of patients with spasticity due to multiple sclerosis was unsuccessful in demonstrating that the drug provided statistically significant improvement compared with placebo in the trial's co-primary endpoints.
Mon May 20, 2013
5 unique and outside-the-box multiple sclerosis researched therapies
Multiple sclerosis , a neurological disease that affects millions of people all across the world, harms everyone who has this disease is such unbelievable ways and, as of yet, finding a cure has proved incredibly allusive.
XenoPort to drop multiple sclerosis drug after trial failure
XenoPort Inc said it will stop developing its experimental multiple sclerosis treatment after data from a late-stage trial showed the drug did not improve patients' condition significantly compared with a placebo.
Sun May 19, 2013
The Motley Fool
Multiple Sclerosis and Hemophilia: This Biotech's Just Getting Started
In this video, health-care analyst David Williamson discusses why Biogen Idec 's party may just be getting started despite a huge run in the stock already.
'Only cannabis spray relieves my MS - so why won't the NHS give it to ...
'Only cannabis spray relieves my MS - so why won't the NHS give it to me?' Sufferer refused drug to help ease affects of disease Mr Rudd was refused Sativex on the NHS while sufferers living a few miles away are being prescribed the cannabis spray The drug hasn't been assessed by the National Institute for Health and Clinical Excellence - meaning ... (more)
Sat May 18, 2013
A Walk to Remember for MS
Walk MS brings together people of all walks of life for the common goal of curing the nervous system disease.
A charity supporter is aiming to travel 101 miles along the South Downs Way on his mobility scooter.
A charity supporter is aiming to raise A 10,000 for charity - by travelling 101 miles along the South Downs Way on his mobility scooter.
Fri May 17, 2013
Young scientists shine in AZ competition
It is the largest high school science competition in the world and it's happening right here in the Valley.
Study identifies new approach to improving treatment for MS and other conditions
Working with lab mice models of multiple sclerosis , UC Davis scientists have detected a novel molecular target for the design of drugs that could be safer and more effective than current FDA-approved medications against MS.
Thu May 16, 2013
New York Daily News
Scientists successfully create human stem cells through cloning
The feat, which has been attempted without success for almost two decades, could lead to new treatments for diseases like Parkinson's and multiple sclerosis.
The Jersey Journal
Hamilton motorcyclist refuses to let multiple sclerosis slow him down
Mike Pawelczak has had MS for over 30 years and leads a group of motorcycle riders, who provide support for cyclists.
Research and Markets: Laquinimod (Multiple Sclerosis) - Forecast and Market Analysis to 2022
Teva's and Active Biotech's laquinimod is a synthetic, once-daily, orally-administered immunomodulator under investigation for the treatment of RRMS.
A multiple sclerosis sufferer from North Finchley has raised nearly 5000 for charity.
Paula Sanchez, 23, who was diagnosed with the condition five months ago, gathered together celebrities and cake lovers to raise money for the Multiple Scleroisis Society during an event at the Hyatt Regency Hotel last month.